Join us in Las Vegas for this Midday Symposium Conducted at the 2022 ASHP Midyear Clinical Meeting & Exhibition!

Evolving Considerations for Prevention and Management of COVID 19—Let’s Not Forget the Immunocompromised Patient!

COVID-19 continues to pose a significant health risk, especially to those who cannot receive or do not respond to vaccination. As new variants emerge and data become available, it is important for pharmacists to stay abreast of these changes. This presentation will highlight expert guidance for optimizing treatment and prevention of COVID-19 in the immunocompromised as well as strategies for reaching the target population.

Monday, Dec. 5
11:30 a.m. - 1 p.m. PT

Come early! Seating is limited and provided on a first-come, first-served basis.

Symposium Location: Islander Ballroom H, Lower Level, Mandalay Bay North Convention Center

Can't make it to Vegas? Tune into the Live Webinar Broadcast: 

Monday, Dec. 5

11:30 a.m. - 1 p.m. PT (2:30 - 4 p.m. ET)

Registration required. Please click button below.  

Featuring...

Katherine Young

PharmD, MPH, FCSHP
Activity Chair

Clinical Professor
University of California, San Francisco (UCSF) School of Pharmacy
Infectious Diseases Clinical Pharmacist
UCSF Medical Center
San Francisco, California

Monica V. Mahoney

PharmD, BCPS, BCIDP, FCCP

Clinical Pharmacy Specialist,
Infectious Diseases
Outpatient ID/OPAT Clinics
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Sarah Parsons

PharmD, BCPPS

Clinical Pharmacy Specialist Pediatric Infectious Diseases, Antimicrobial Stewardship,
Cystic Fibrosis
The Children's Hospital of the King's Daughters
Norfolk, Virginia

Michael Ganio

PharmD, MS, BCSCP, FASHP

Moderator

Senior Director
Pharmacy Practice and Quality
ASHP
Bethesda, Maryland

Target Audience

This activity was planned to meet the educational needs of pharmacists who want to optimize treatment and prevention of COVID-19 in the immunocompromised population.

Learning Objectives

• Describe the pharmacist’s role in prevention and treatment strategies for immunocompromised patients at risk for COVID-19 infection.
• Discuss the role of pre-exposure prophylaxis in an immunocompromised patient.
• Create a treatment plan for an immunocompromised patient with COVID-19 infection.
• Summarize prevention and management strategies for COVID-19 in immunocompromised pediatric patients.

Agenda

11:30 a.m. - Welcome and Introductions
Michael Ganio, PharmD, MS, BCSCP, FASHP (Moderator)

11:40 a.m. - State of COVID-19; Prevention strategies for immunocompromised patients
Katherine Yang, PharmD, MPH, FCSHP

12:00 p.m. - COVID-19 treatment in immunocompromised patients

Monica Mahoney, PharmD, BCPS, BCIDP, FCCP

12:20 p.m. - Considerations for prevention and management of COVID-19 in immunocompromised pediatric patients
Sarah Parsons, PharmD, BCPPS

12:35 p.m. - Cases/Unique models for reaching the target population
All faculty

12:50 p.m. - Faculty Discussion and Questions and Answers
All faculty

Accredited for CPE

ACPE #: 0204-0000-22-422-L01-P

CE Credit: 1.5 contact hours (0.15 CEUs)

Activity Type: Application-based

Activity Fee: No charge

To Claim CE for this free webinar, enter the CE code announced during the activity and complete the evaluation.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Provided by ASHP.
Supported by an educational grant from AstraZeneca Inc.
For questions and assistance to participate, contact us.